Quality of Life in Urticaria

  • M. Özkan
  • S. Özkan
  • N. Kocaman Yildirim
Reference work entry


The measurement of the quality of life is an important aspect in determining the impact of disease and treatment on the patient and in evaluating the health care. Although, heath-related quality-of-life (HRQOL) is evaluated in many medical diseases, assessment of HRQOL in urticaria patients had been neglected, even though the impact of skin diseases on patients’ lives may be more complex than that of other diseases. Urticaria is one of the most common skin disorders. As urticaria is accepted as not involving pain, quality of life measurements related to urticaria are limited, but have increased in recent years. Urticaria symptoms and treatment affect everyday life, limiting and impairing physical and emotional functioning. The quality of life of urticaria patients was measured with generic or dermatology specific HRQOL; however, in recent years a measurement tool specific to urticaria has been developed. The impact of urticaria on HRQOL is rated by patients at similar or higher levels compared to other chronic skin disorders and life threatening diseases. Studies have shown that urticaria greatly affects patients’ quality of life. The HRQOL of patients with urticaria was lower both in physical and psychological health parameters when compared with healthy controls or other skin disease patients and medical patients. Urticaria patients frequently exhibit psychiatric comorbidity. These psychiatric disorders can influence HRQOL. In the related literature, HRQOL was associated with levels of anxiety and depressive symptoms rather than urticarial symptoms. It is clear that quality of life is important in urticaria patients and it is suggested that an interdisciplinary approach that combines dermatological and psychiatric treatment is required for improving the quality of life in these patients.


Atopic Dermatitis Chronic Urticaria Dermatology Life Quality Index Nottingham Health Profile Chronic Idiopathic Urticaria 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations:


atopic dermatitis


chronic idiopathic urticaria


chronic urticaria

CU-Q2oL questionnaire

The Chronic Urticaria Quality of Life Questionnaire


The Dermatology Life Quality Index


European Academy of Allergology and Clinical Immunology


Global Allergy and Asthma European Network


heath-related quality-of-life


Nottingham Health Profile




quality of life


Medical Outcome Study Short Form 36


The VQ-Dermato questionnaire


World Health Organization Quality of Life Assessment-Brief


  1. Aksu AEK, Urer MS, Sabuncu İ, Saracoğlu N, Chren MM. (2007). Int J Dermatol. 46: 350–355.PubMedCrossRefGoogle Scholar
  2. Arnold HL, Odom RB, James WD. (1990) Diseases of the Skin. 8th ed. Saunders, Philadelphia, pp. 68–88, 131–158, 194–222.Google Scholar
  3. Baiardini I, Pasquali M, Braido F, Fumagalli F, Guerra L, Compalati E, Braga M, Lombardi C, Fassio O, Canonica GW. (2005). Allergy. 60: 1073–1078.PubMedCrossRefGoogle Scholar
  4. Baiardini I, Giardini A, Pasquali M, Dignetti P, Guerra L, Specchia C, Braido F, Majani G, Canonica GW. (2003). Allergy. 58: 621–623.PubMedCrossRefGoogle Scholar
  5. Champion RH. (1988). Br J Dermatol. 119: 427–436.PubMedCrossRefGoogle Scholar
  6. Chren MM. (1997). Arch Dermatol. 133: 1433–1440.PubMedCrossRefGoogle Scholar
  7. Di Marco F, Verga M, Reggente M et al. (2006). Respir Med 100: 1767–1774.PubMedCrossRefGoogle Scholar
  8. Engin B, Uguz F, Yilmaz E, Özdemir M, Mevlitoglu I. (2008). J Eur Acad Dermatol Venereol 22: 36–40.PubMedGoogle Scholar
  9. Finlay AY. (1997). Br J Dermatol. 136: 305–314.PubMedCrossRefGoogle Scholar
  10. Finlay AY, Khan GK. (1994). Clin Exp Dermatol 9: 210–216.CrossRefGoogle Scholar
  11. Ginsburg IH, Link BG. (1989). J Am Acad Dermatol. 20: 53–63.PubMedCrossRefGoogle Scholar
  12. Greaves MW. (1995). N Engl J Med. 332(26): 1767–1772.PubMedCrossRefGoogle Scholar
  13. Greaves MW. (2000). Clin Immunol. 105: 664–672.Google Scholar
  14. Greaves MW. (2001). ACI Int. 13(1): 23–26.Google Scholar
  15. Greaves MW. (2002). Int Arch Allergy Immunol. 127: 3–9.PubMedCrossRefGoogle Scholar
  16. Grop JJ, Auquier P, Dreyfus I, Ortenne JP. (2008). J Eur Acad Dermatol Venereol. 22: 87–93.Google Scholar
  17. Grob JJ, Auquier P, Martin S, Lancon C, Bonerandi JJ. (1999). Dermatology. 199: 213–222.PubMedCrossRefGoogle Scholar
  18. Grob JJ, Gaudy-Marqueste C. (2006). Clin Rev Allergy Immunol. 30: 47–51.PubMedCrossRefGoogle Scholar
  19. Grob JJ, Revuz J, Ortonne JP, Auquier P Lorette G. (2005). Br J Dermatol. 152: 289–295.PubMedCrossRefGoogle Scholar
  20. Guyatt GH, Feeny DH & Patrick DL. (1993). Ann Intern Med 118: 622–629.PubMedGoogle Scholar
  21. Hide M, Francis DM, Grattan C, Hakimi J, Kochan JP, Greaves MW. (1993). N Engl J Med. 328: 1599–1604.PubMedCrossRefGoogle Scholar
  22. Hunt SM, McKenna SP, McEwen J, Backett EM, Williams J, Papp E. (1980). J Epidemiol Community Health. 34: 281–286.PubMedCrossRefGoogle Scholar
  23. Janardhan V, Bakshi R. (2002). J Neurol Sci. 205: 51–58.PubMedCrossRefGoogle Scholar
  24. Jayaprakasam A, Darvay A, Osborne G, McGibbon D. (2002). Clin Exp Dermatol. 27: 306–308.PubMedCrossRefGoogle Scholar
  25. Katugampola RP, Lewis VJ, Finlay AY. (2007). Br J Dermatol. 156: 945–950.PubMedCrossRefGoogle Scholar
  26. Kaya N, Akpçnar Z, Çilli AS. (2003). Anatolian J Psychiatry. 4: 220–225 (in Turkish).Google Scholar
  27. Koo J. (1995). J Am Acad Dermatol 32: 26–30.CrossRefGoogle Scholar
  28. Lennox RD, Leahy MJ. (2004). Ann Allergy Asthma Immunol. 93: 142–146.PubMedCrossRefGoogle Scholar
  29. Maniaci G, Epifanio MS, Marino MA, Amoroso S. (2006). Allerg Immunol 38(1): 15–19.Google Scholar
  30. Maurer M, Dechene M, Staubach P et al. (2003). Allergo J 12: 54.Google Scholar
  31. McCombs K, Chen SC. (2007). Dermatol Ther. 20: 102–109.PubMedCrossRefGoogle Scholar
  32. O’Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. (1997). Br J Dermatol. 136: 197–201.PubMedCrossRefGoogle Scholar
  33. Özkan M, Corapcioglu A, Balcioglu I, Ertekin E, Khan S, Ozdemir S, Karayun D, Unsalver BO, Kocaman N, Kaymakglu S, Koroglu G. (2006). Int J Psychiatry Med. 36(3): 283–297.PubMedCrossRefGoogle Scholar
  34. Özkan M, Oflaz SB, Kocaman N, Ozseker F, Gelincik A, Büyüköztürk S, Ozkan S, Colakoglu B. (2007). Ann Allergy Asrhma Immunol. 99(1): 29–33.CrossRefGoogle Scholar
  35. Öztürkcan S, Ermertcan AT, Eser E, Şahin MT. (2006). Int J Dermatol. 45: 1300–1307.PubMedCrossRefGoogle Scholar
  36. Picardi A, Abeni D, Melchi CF, Puddu P Pasquini P. (2000). Br J Dermatol. 143: 983–991.PubMedCrossRefGoogle Scholar
  37. Picardi A, Amerio P, Baliva G, Barbieri C, Teofoli P, Bolli S, Salvatori V, Mazzotti E, Pasquini P, Abeni D. (2004). Acta Derm Venereol. 84: 213–217.PubMedCrossRefGoogle Scholar
  38. Piccinni A, Maser JD, Bazzichi L. et al. (2006). Compr Psychiatry. 47: 201–208.PubMedCrossRefGoogle Scholar
  39. Poon E, Seed PT, Greaves MW, Kobza-Black A. (1999). Br J Dermatol. 140: 667–671.PubMedCrossRefGoogle Scholar
  40. Raap U, Gieler U, Schmid-Ott G. (2004). Dermatol Psychosom. 5: 203–205.CrossRefGoogle Scholar
  41. Ryan TJ. (1991). Br J Hosp Med. 46: 33–36.PubMedGoogle Scholar
  42. Sabroe RA, Greaves MW. (1997). Arch Dermatol. 133: 1003–1008.PubMedCrossRefGoogle Scholar
  43. Schipper H, Clinch J, Olweny CLM. (1990). In: Spilker B, (ed). Quality of life and pharmacoeconomics in cinical trials. Lippincot-Raven, Philadelphia, pp.11–23.Google Scholar
  44. Shikiar R, Harding G, Leahy M, Lennox RD. (2005). Health Qual Life Outcomes. 3: 36.PubMedCrossRefGoogle Scholar
  45. Sibbald RG, Cheema AS, Lozinski A, Tarlo S. (1991). Int J Dermatol. 30: 381–386.PubMedCrossRefGoogle Scholar
  46. Staubach P, Eckhardt-Henn A, Dechene M, Vonend A, Metz M, Magerl M, Breuer P, Maurer M. (2006). Br J Dermatol. 154: 294–298.PubMedCrossRefGoogle Scholar
  47. Testa MA, Simonson DC. (1996). N Engl J Med. 334: 835–840.PubMedCrossRefGoogle Scholar
  48. Uguz F, Dursun R, Kaya N, Çilli AS. (2006). Anatolian J Psychiatry. 7: 133–139 (in Turkish).Google Scholar
  49. Van Der Valk PGM, Moret G, Kiemeney LALM. (2002). Br J Dermatol. 146: 110–113.PubMedCrossRefGoogle Scholar
  50. Weldon DR. (2006). Allergy Asthma Proc. 27: 96–99.PubMedCrossRefGoogle Scholar
  51. Ware JE, Sherbourne CD. (1992). Med Care. 30: 473–483.PubMedCrossRefGoogle Scholar
  52. WHOQOL Group. (1998). Psychol Med. 28: 551–558.CrossRefGoogle Scholar
  53. Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CEH, Greaves MW, Henz BM, Kapp A, Kozel MMA, Maurer M, Merk HF, Schafer T, Simon D, Vena GA, Wedi B. (2006). Allergy 61: 316–332.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2010

Authors and Affiliations

  • M. Özkan
    • 1
  • S. Özkan
    • 1
  • N. Kocaman Yildirim
    • 1
  1. 1.Department of Psychiatry, Department of Consultation Liaison PsychiatryUniversity of Istanbul, Istanbul Faculty of Medicine, ÇapaIstanbulTurkey

Personalised recommendations